BARCLAYS PLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 1 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$362
-42.5%
245,243
+23.7%
0.00%
Q2 2023$630
+8.8%
198,268
-19.2%
0.00%
Q1 2023$579
-50.3%
245,251
-26.9%
0.00%
-100.0%
Q4 2022$1,164
-99.9%
335,408
+149.0%
0.00%0.0%
Q3 2022$988,000
+1633.3%
134,708
+1451.2%
0.00%
Q2 2022$57,000
-65.2%
8,684
-73.4%
0.00%
Q1 2022$164,00032,6390.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders